Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

BRX1, Biogenesis of Ribosomes, Homolog (BRIX1) (Middle Region) Peptid

BRIX1 Reaktivität: Human Wirt: Synthetic BP, WB
Produktnummer ABIN973949

Kurzübersicht für BRX1, Biogenesis of Ribosomes, Homolog (BRIX1) (Middle Region) Peptid (ABIN973949)

Target

BRIX1 (BRX1, Biogenesis of Ribosomes, Homolog (BRIX1))

Spezies

Human

Quelle

  • 2
Synthetic

Applikation

Blocking Peptide (BP), Western Blotting (WB)
  • Protein Region

    Middle Region

    Sequenz

    IWFRNFQIIE EDAALVEIGP RFVLNLIKIF QGSFGGPTLY ENPHYQSPNM

    Produktmerkmale

    This is a synthetic peptide designed for use in combination with anti-BXDC2 Antibody(ARP57202_P050),. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.

    Aufreinigung

    Purified
  • Applikationshinweise

    Each Investigator should determine their own optimal working dilution for specific applications.

    Beschränkungen

    Nur für Forschungszwecke einsetzbar
  • Format

    Lyophilized

    Rekonstitution

    Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.

    Konzentration

    1 mg/mL

    Buffer

    Final peptide concentration is 1 mg/mL in PBS.

    Handhabung

    Avoid repeated freeze-thaw cycles.

    Lagerung

    -20 °C

    Informationen zur Lagerung

    For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
  • Target

    BRIX1 (BRX1, Biogenesis of Ribosomes, Homolog (BRIX1))

    Hintergrund

    BXDC2 is required for biogenesis of the 60S ribosomal subunit.

    Alias Symbols: BRIX, BXDC2, FLJ11100

    Protein Interaction Partner: CD48,SETDB1,UBA2,UNC119,CD48,CDC42BPB,CNBP,LYAR,SETDB1,UBA2,UNC119

    Protein Size: 353

    Molekulargewicht

    41 kDa

    Gen-ID

    55299

    NCBI Accession

    NM_018321, NP_060791

    UniProt

    Q8TDN6
Sie sind hier:
Chat with us!